SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-020335
Filing Date
2023-04-26
Accepted
2023-04-25 20:40:57
Documents
14
Period of Report
2023-04-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc20051944_8k.htm   iXBRL 8-K 25803
2 EXHIBIT 99.1 brhc20051944_ex99-1.htm EX-99.1 31017
6 logo1.jpg GRAPHIC 7942
  Complete submission text file 0001140361-23-020335.txt   212301

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ions-20230425.xsd EX-101.SCH 3874
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20230425_lab.xml EX-101.LAB 22546
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20230425_pre.xml EX-101.PRE 16050
8 EXTRACTED XBRL INSTANCE DOCUMENT brhc20051944_8k_htm.xml XML 4070
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 23846520
SIC: 2834 Pharmaceutical Preparations